Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMF237 in Japanese patients with type 2 diabetes inadequately controlled with vildagliptin
NCT01811485Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vildagliptin + metformin in type 2 diabetes mellitus (T2DM), sponsored by Novartis. Started May 2013; status: completed.
02
Drugs
vildagliptin + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01811485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01811485.